Fil LTD Pro Qr Therapeutics N.V. Transaction History

Fil LTD

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.74 - $0.89 $117,537 - $141,362	-158,834 Reduced 15.01%	899,257 $669,000
Q2 2022 Aug 12, 2022	SELL	$0.56 - $1.0 $26,321 - $47,002	-47,002 Reduced 4.25%	1,058,091 $823,000
Q1 2022 May 13, 2022	BUY	$0.9 - $8.39 $73,141 - $681,838	81,268 Added 7.94%	1,105,093 $1 Million
Q4 2021 Feb 14, 2022	SELL	$6.58 - $8.44 $1.2 Million - $1.54 Million	-181,935 Reduced 15.09%	1,023,825 $8.2 Million
Q3 2021 Nov 15, 2021	BUY	$5.16 - $8.47 $918,263 - $1.51 Million	177,958 Added 17.31%	1,205,760 $10.1 Million
Q2 2021 Aug 13, 2021	BUY	$5.75 - $7.59 $2.13 Million - $2.81 Million	370,340 Added 56.33%	1,027,802 $6.93 Million
Q1 2021 May 14, 2021	BUY	$4.14 - $9.22 $1.35 Million - $3.01 Million	326,258 Added 98.51%	657,462 $4.35 Million
Q3 2020 Nov 13, 2020	BUY	$4.79 - $6.3 $668,636 - $879,417	139,590 Added 72.85%	331,204 $1.59 Million
Q2 2020 Aug 13, 2020	BUY	$4.5 - $6.53 $505,674 - $733,789	112,372 Added 141.81%	191,614 $1.17 Million
Q1 2020 May 14, 2020	BUY	$5.25 - $9.9 $141,844 - $267,478	27,018 Added 51.73%	79,242 $435,000
Q4 2019 Feb 07, 2020	BUY	$5.84 - $10.51 $70,132 - $126,214	12,009 Added 29.86%	52,224 $518,000
Q3 2019 Nov 13, 2019	BUY	$5.76 - $9.44 $231,638 - $379,629	40,215 New	40,215 $232,000

17.4M

37.7K

21.3K

Ticker PRQR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,362,096
Market Cap $157M
Description
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

Stay updated on Fil LTD with notifications on news.